Biobank on Prematurity, Preeclampsia and Other Pregnancy Complications

RecruitingOBSERVATIONAL
Enrollment

7,845

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2028

Conditions
PreeclampsiaPreterm BirthPregnancy ComplicationsFetal Anomalies
Interventions
OTHER

Observational

"All women of the biobank have provided:~1. blood samples (plasma, serum and Buffy-coat)~2. urine samples~3. demographic and clinical data (maternal age, BMI, smoking status, obstetrical and medical history)~4. mean arterial blood pressure~5. ultrasound examination (datation of pregnancy at recruitment, uterine arteries doppler, placental volume, nuchal translucency in the majority of the cases)~6. access to medical record (for pregnancy/delivery outcomes, newborn birthweight, gestational age at delivery)"

Trial Locations (1)

G1V 4G2

RECRUITING

CHU de Quebec, Québec

All Listed Sponsors
lead

CHU de Quebec-Universite Laval

OTHER